Metabolic surgery improves brain glucose metabolism, cognitive function and neuroplasticity in obese non-diabetic subjects

被引：0
|
作者：
Daniele, G. [1 ]
Angela, D. [1 ]
Volterrani, D. [1 ]
Giusti, L. [1 ]
Ciccarone, A. [2 ]
Aghakhanyan, G. [1 ]
Ceccarini, G. [1 ]
Santini, F. [1 ]
Moretto, C. [2 ]
Binda, P. [1 ]
Lunghi, C. [1 ]
Morrone, C. [1 ]
Del Prato, S. [1 ]
机构：
[1] Univ Pisa, Pisa, Italy
[2] Azienda Osped Univ Pisana, Pisa, Italy
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
93
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [21] Plasma glucose levels and cognitive function in non-diabetic older adults
    Waldstein, SR
    Maier, KJ
    Katzel, LI
    PSYCHOSOMATIC MEDICINE, 2000, 62 (01): : 115 - 115
  • [22] Improvement of metabolic parameters and vascular function by metformin in obese non-diabetic rats
    Lobato, N. S.
    Filgueira, F. P.
    Hagihara, G. N.
    Akamine, E. H.
    Pariz, J. R.
    Tostes, R. C.
    Carvalho, M. H. C.
    Fortes, Z. B.
    LIFE SCIENCES, 2012, 90 (5-6) : 228 - 235
  • [23] Glucose sensors and transporters in metabolic disease: analysis of tissue from obese diabetic and non-diabetic humans
    Bhutta, H. Y.
    Tavakkoli, A.
    BRITISH JOURNAL OF SURGERY, 2014, 101 : 30 - 30
  • [24] Impact of metabolic syndrome on subclinical changes of vascular structure and function in diabetic and non-diabetic subjects
    Wong, C.
    Haluska, B.
    Jeffriess, L.
    O'Moore-Sullivan, T.
    Marwick, T. H.
    EUROPEAN HEART JOURNAL, 2005, 26 : 340 - 340
  • [25] Beta cell amount, function and turnover in non-diabetic obese vs lean subjects
    Marselli, L.
    Suleiman, M.
    Occhipinti, M.
    Olimpico, F.
    Syed, F.
    Bugliani, M.
    Marchetti, P.
    DIABETOLOGIA, 2015, 58 : S239 - S239
  • [26] SOMATOSTATIN RESPONSE TO GLUCOSE BEFORE AND AFTER PROLONGED FASTING IN LEAN AND OBESE NON-DIABETIC SUBJECTS
    VERRILLO, A
    DETERESA, A
    MARTINO, C
    DICHIARA, G
    VERRILLO, L
    REGULATORY PEPTIDES, 1988, 21 (3-4) : 185 - 195
  • [27] Rimonabant improves oral glucose tolerance in non-diabetic overweight/obese patients with/without comorbidities
    Van Gaal, L. F.
    Despres, J. P.
    Golay, A.
    Rissanen, A.
    DIABETIC MEDICINE, 2007, 24 : 5 - 5
  • [28] Rimonabant improves oral glucose tolerance in non-diabetic overweight/obese patients with/without comorbidities
    Despres, Jean-Pierre
    Van Gaal, Luc
    Glay, Alain
    Rissanen, Aila
    DIABETES, 2006, 55 : A80 - A81
  • [29] THE SIGNIFICANCE OF THE METABOLIC SYNDROME IN THE DEVELOPMENT OF CHRONIC RENAL DISEASE (CKD) IN NON-DIABETIC OBESE SUBJECTS
    Ohni, M.
    Nakajima, K.
    Hata, Y.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [30] Inhibition of beta-oxidation improves hepatic steatosis and metabolism in obese non-diabetic humans
    Borra, Ronald
    Maggio, Romina
    Kankaanpaeae, Mikko
    Parkkola, Riitta
    Naum, Alexandru
    Tuunanen, Helena
    Nagren, Kjell
    Viljanen, Tapio
    Ferrannini, Ele
    Nuutila, Pirjo
    Iozzo, Patricia
    DIABETES, 2007, 56 : A393 - A393
12345